The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Adults hospitalized for RSV face higher odds of cardiac complications than those with COVID-19 or influenza, especially in ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...

June 2, 2025 - Last Friday, the World Health Organization (WHO) published its first-ever position paper on immunization ...

The announcement comes as part of WHO’s broader effort to reduce child mortality, particularly in low- and middle-income ...

Odds of any acute cardiovascular event increased when compared with COVID-19 hospitalizations in boosted and unboosted individuals.

The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

The World Health Organization (WHO) has published its first ever position paper on immunization against respiratory syncytial ...